William B. Coleman

William B. Coleman, PhD is Appointed Executive Officer of the American Society for Investigative Pathology

Monday, February 5th, 2018
American Society for Investigative Pathology

Following a national search conducted by the Sterling Martin Associates team, the American Society for Investigative Pathology (ASIP) has appointed William Coleman, PhD as ASIP’s Executive Officer. He will succeed Mark E. Sobel, MD, PhD on February 1, 2018. Sobel has served as ASIP’s Executive Officer since 2001. Dr. Coleman is currently Professor in the Department of Pathology and Laboratory Medicine at the University of North Carolina School of Medicine (Chapel Hill, NC).

Coleman received his BS from Wingate College in 1986 and his PhD in Biochemistry from the Bowman Gray School of Medicine/Wake Forest University in 1990 under the mentorship of Dr. Carol C. Cunningham. Dr. Coleman was a postdoctoral fellow in the Department of Pathology and Laboratory Medicine at the University of North Carolina working in the laboratory of Dr. Joe W. Grisham from 1990 to1995 and subsequently joined the faculty in that department. In addition to being a Professor in the Department of Pathology and Laboratory Medicine, Dr. Coleman holds faculty appointments in the Curriculum in Toxicology and the Cancer Biology Training Program, is a member of the UNC Lineberger Comprehensive Cancer Center, and is Director of the UNC Program in Translational Medicine.

Dr. Coleman is recognized as one of the leading researchers in the fields of liver and breast carcinogenesis. He has been the recipient of numerous institutional grant awards, and funding from the Susan G. Komen Breast Cancer Foundation, the National Cancer Institute, and Friends for an Earlier Breast Cancer Test (Earlier.org). The work from his laboratory has resulted in over >135 peer-reviewed papers, book chapters, and reviews. In addition, Dr. Coleman is co-author or co-editor of nine text books on topics related to molecular pathology, and is co-editor of a book series on molecular and translational medicine.

Dr. Coleman has received many honors, including the ASIP Outstanding Investigator Award (2013) and the Blue Faery Award for Excellence in Liver Cancer Research (2011). At UNC, Dr. Coleman is a four-time recipient of the Joe W. Grisham Award for Excellence in Graduate Student Teaching (2000, 2002, 2009, 2012) and recipient of the Faculty Merit Award for Outstanding Teaching and Mentoring (2016).

Dr. J. Charles Jennette, Chair of the Department of Pathology and Laboratory Medicine at the University of North Carolina, describes Dr. Coleman as ”an accomplished cancer researcher who is elucidating previously unrecognized mechanisms for epigenetic regulation of normal and abnormal gene expression.” In addition, “to a much greater extent than most other accomplished investigators,” Dr. Jennette commends Dr. Coleman as making “the extra effort to be a major player in local and national educational efforts, and to make sustained major contributions to societies that advance basic biomedical research, especially the ASIP.”

Dr. Coleman has been a member of the ASIP for >20 years, and his contributions to the Society include service as Program Committee Chair (2002-2004), Councilor (2004-2007), Secretary-Treasurer (2007-2013), and President (2015-2016), as well as participation in many committees. Dr. Coleman will be the third Executive Officer in the history of the organization who is a former President.